1. Screening Libraries
  2. Histone Modification Research Compound Library

Histone Modification Research Compound Library

Cat. No.: HY-L024
Library Contents: XLSX PDF

A unique collection of 179 bioactive compounds targeting histone modification for high throughput screening (HTS) and high content screening (HCS).

Histone Modification Research Compound Library
Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products
  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 179 bioactive compounds for high throughput screening (HTS) and high content screening (HCS).

•   Targets include Epigenetic Reader Domain, HDAC, Histone Acetyltransferase, Histone Demethylase, Histone Methyltransferase, Sirtuin, etc.

•   A useful tool for the research of the regulation of histone modification and the corresponding diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   More detailed compound information with structure, IC50, and brief introduction.

•   NMR and HPLC validated to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 179 histone modification related compounds supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Histone Modification Research Compound Library

Source: MedChem Express

Contents of Histone Modification Research Compound Library

Plate layout: HY-L024-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Mivebresib HLCL-61 (hydrochloride) GSK6853 EPZ015866 BI-7273 BI-9564 MS049 Remetinostat NKL 22 CPI-455 Empty
b Empty CPI-637 ITSA-1 GSK-LSD1 Dihydrochloride AGK2 BVT948 AZD5153 (6-Hydroxy-2-naphthoic acid) Cambinol Histone Acetyltransferase Inhibitor II AS8351 UNC3866 Empty
c Empty WT-161 Salermide EED226 666-15 SIRT2 Inhibitor II GSK3326595 dBET1 WM-1119 Vorinostat CUDC-101 Empty
d Empty Panobinostat Belinostat BET bromodomain inhibitor KG-501 EED inhibitor-1 PF-06726304 CAY10602 Tasquinimod Valproic acid Valproic acid (sodium salt) Empty
e Empty BIX-01294 BAY-299 OSS_128167 3-TYP Tucidinostat UNC0224 UNC0321 Abexinostat HDAC8-IN-1 SR-4370 Empty
f Empty PLX51107 CeMMEC1 ZL0420 (+)-JQ1 PA GSK 690 (Hydrochloride) JQ-35, (S)- Entinostat Mocetinostat MM-102 (TFA) IOX1 Empty
g Empty UNC0379 PFI-3 OF-1 A-366 SP2509 ML324 ORY-1001(trans) GSK503 PTACH (+)-JQ-1 Empty
h Empty (R)-(-)-JQ1 Enantiomer Molibresib I-BET151 Droxinostat Tubastatin A (Hydrochloride) Tubastatin-A Pracinostat Tenovin-1 GSK126 GSK343 Empty

Plate layout: HY-L024-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty M344 Sirtinol Fimepinostat Dacinostat Daminozide Sulforaphane Tazemetostat UNC0646 C646 RGFP966 Empty
b Empty JIB-04 MS436 GSK1324726A UNC0642 Resminostat (hydrochloride) Givinostat (hydrochloride monohydrate) Trichostatin A MI-2 MI-3 PCI-34051 Empty
c Empty EPZ004777 UNC0638 Selisistat Scriptaid Tenovin-6 Tenovin 6 (Hydrochloride) EI1 Pinometostat UNC1999 BRD9539 Empty
d Empty GSK-J1 GSK-J2 GSK-J4 UNC1215 SGC0946 Sodium phenylbutyrate GSK2801 Birabresib Bromosporine SGC-CBP30 Empty
e Empty UNC 669 CPI-203 Inauhzin MG 149 C-7280948 CPI-169 racemate Citarinostat Domatinostat (tosylate) Domatinostat Ricolinostat Empty
f Empty RG2833 PFI-1 Apabetalone AK-7 BRD4770 Remodelin (hydrobromide) MC1568 EPZ011989 OICR-9429 TMP269 Empty
g Empty TMP195 PFI-2 (hydrochloride) GSK2879552 PFI-4 GSK-5959 BRD73954 BG45 AMI-1 I-BRD9 UF010 Empty
h Empty LMK-235 LLY-507 ACY-738 WDR5-0103 Pimelic Diphenylamide 106 BML-210 NI-57 MS023 XY1 SGC707 Empty

Plate layout: HY-L024-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty HPOB 4-(2-(5-(3,5-Dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine hydrochloride BCI-121 BI 2536 Tacedinaline JQ-1 (carboxylic acid) Benzenebutyric acid Nicotinamide Sodium Butyrate Bufexamac Empty
b Empty Amodiaquin (dihydrochloride dihydrate) Tranylcypromine (hemisulfate) Curcumin Fisetin Ginkgolide C Santacruzamate A Dihydrocoumarin Anacardic Acid Sinapinic acid Empty Empty
c Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
d Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Histone Modification Research Compound Library
Cat. No.:
HY-L024
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.